Designed zinc finger protein interacting with the HIV-1 integrase recognition sequence at 2-LTR-circle junctions

Protein Science

Volumn 18, Issue 11, 2009, Pages 2219-2230

  Sakkhachornphop, Supachai ^a   Jiranusornkul, Supat ^a   Kodchakorn, Kanchanok ^a   Nangola, Sawitree ^a   Sirisanthana, Thira ^a   Tayapiwatana, Chatchai ^a  

^a CHIANG MAI UNIVERSITY   (Thailand)

Author keywords

2 LTR circle junctions; AIDS; HIV 1; Molecular modeling; Zinc finger protein

Indexed keywords

INTEGRASE; ZINC FINGER PROTEIN;

ARTICLE; BINDING AFFINITY; CHEMICAL INTERACTION; CONTROLLED STUDY; DISSOCIATION CONSTANT; ESCHERICHIA COLI; FEMALE; GEL MOBILITY SHIFT ASSAY; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN IMMUNODEFICIENCY VIRUS 1; HYDROGEN BOND; LONG TERMINAL REPEAT; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; RECOGNITION; SURFACE PLASMON RESONANCE;

AMINO ACID SEQUENCE; BASE SEQUENCE; CLONING, MOLECULAR; DNA; DNA-BINDING PROTEINS; ELECTROPHORETIC MOBILITY SHIFT ASSAY; HELA CELLS; HIV INTEGRASE; HIV LONG TERMINAL REPEAT; HIV-1; HUMANS; KINETICS; MODELS, BIOLOGICAL; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PROTEIN BINDING; SURFACE PLASMON RESONANCE; THERMODYNAMICS; ZINC FINGERS;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 70350511438     PISSN: 09618368     EISSN: 1469896X     Source Type: Journal    
DOI: 10.1002/pro.233     Document Type: Article

References (53)

1. Mann JM, Chin J, Piot P, Quinn T (1988) The international epidemiology of AIDS. Sci Am 259:82-89.
2. UNAIDS/World Health Organization (2008) Report on the Global HIV/AIDS Epidemic. August, Mexico City.
3. Englund G, Theodore TS, Freed EO, Engelman A, Martin MA (1995) Integration is required for productive infection of monocyte-derived macrophages by human immunodeficiency virus type 1. J Virol 69:3216-3219.
4. Engelman A, Englund G, Orenstein JM, Martin MA, Craigie R (1995) Multiple effects of mutations in human immunodeficiency virus type 1 integrase on viral replication. J Virol 69:2729-2736.
5. Sakai H, Kawamura M, Sakuragi J, Sakuragi S, Shibata R, Ishimoto A, Ono N, Ueda S, Adachi A (1993) Integration is essential for efficient gene expression of human immunodeficiency virus type 1. J Virol 67:1169-1174. (Pubitemid 23067618)
6. Swanstrom R, Delorbe WJ, Bishop JM, Varmus HE (1981) Nucleotide sequence of cloned unintegrated avian sarcoma virus DNA: viral DNA contains direct and inverted repeats similar to those in transposable elements. Proc Natl Acad Sci USA 78:124-128. (Pubitemid 11131251)
7. Shoemaker C, Goff S, Gilboa E, Paskind M, Mitra SW, Baltimore D (1980) Structure of a cloned circular Moloney murine leukemia virus DNA molecule containing an inverted segment: implications for retrovirus integration. Proc Natl Acad Sci USA 77:3932-3936. (Pubitemid 10015494)
8. Shank PR, Varmus HE (1978) Virus-specific DNA in the cytoplasm of avian sarcoma virus-infected cells is a precursor to covalently closed circular viral DNA in the nucleus. J Virol 25:104-114.
9. Yoshimura FK, Weinberg RA (1979) Restriction endonuclease cleavage of linear and closed circular murine leukemia viral DNAs: discovery of a smaller circular form. Cell 16:323-332.
10. Fritsch E, Temin HM (1977) Formation and structure of infectious DNA of spleen necrosis virus. J Virol 21:119-130. (Pubitemid 8017658)
11. Guntaka RV, Richards OC, Shank PR, Kung HJ, Davidson N (1976) Covalently closed circular DNA of avian sarcoma virus: purification from nuclei of infected quail tumor cells and measurement by electron microscopy and gel electrophoresis. J Mol Biol 106:337-357.
12. Gianni AM, Smotkin D, Weinberg RA (1975) Murine leukemia virus: detection of unintegrated double-stranded DNA forms of the provirus. Proc Natl Acad Sci USA 72:447-451.
13. Vink C, Plasterk RH (1993) The human immunodeficiency virus integrase protein. Trends Genet 9:433-438. (Pubitemid 223004097)
14. Katz RA, Skalka AM (1994) The retroviral enzymes. Annu Rev Biochem 63:133-173.
15. De Clercq E (2001) New developments in anti-HIV chemotherapy. Curr Med Chem 8:1543-1572.
16. Evering TH, Markowitz M (2008) Raltegravir: an integrase inhibitor for HIV-1. Expert Opin Invest Drugs 17:413-422.
17. Grant P, Zolopa A (2008) Integrase inhibitors: a clinical review of raltegravir and elvitegravir. J HIV Ther 13:36-39.
18. Delelis O, Malet I, Na L, Tchertanov L, Calvez V, Marcelin AG, Subra F, Deprez E, Mouscadet JF (2009) The G140S mutation in HIV integrases from raltegravir-resistant patients rescues catalytic defect due to the resistance Q148H mutation. Nucleic Acids Res 37:1193-1201.
19. Hicks C, Gulick RM, Roquebert B, Blum L, Collin G, Damond F, Peytavin G, Leleu J, Matheron S, Chene G, Brun-Vezinet F, Descamps D (2009) Raltegravir: the first HIV type 1 integrase inhibitor selection of the Q148R integrase inhibitor resistance mutation in a failing raltegravir containing regimen. Clin Infect Dis 48:931-939.
20. Charpentier C, Karmochkine M, Laureillard D, Tisserand P, Belec L, Weiss L, Si-Mohamed A, Piketty C (2008) Drug resistance profiles for the HIV integrase gene in patients failing raltegravir salvage therapy. HIV Med 9:765-770.
21. Miller J, Mclachlan AD, Klug A (1985) Repetitive zinc-binding domains in the protein transcription factor IIIA from Xenopus oocytes. EMBO J 4:1609-1614.
22. Lee MS, Gippert GP, Soman KV, Case DA, Wright PE (1989) Three-dimensional solution structure of a single zinc finger DNA-binding domain. Science 245:635-637.
23. Elrod-Erickson M, Rould MA, Nekludova L, Pabo CO (1996) Zif268 protein-DNA complex refined at 1.6 A°: a model system for understanding zinc finger-DNA interactions. Structure 4:1171-1180.
24. Pavletich NP, Pabo CO (1991) Zinc finger-DNA recognition: crystal structure of a Zif268-DNA complex at 2.1 A°. Science 252:809-817.
25. Zimmerman KA, Fischer KP, Joyce MA, Tyrrell DL (2008) Zinc finger proteins designed to specifically target duck hepatitis B virus covalently closed circular DNA inhibit viral transcription in tissue culture. J Virol 82:8013-8021.
26. Dreier B, Segal DJ, Barbas CF (2000) Insights into the molecular recognition of the 5′-GNN-3′ family of DNA sequences by zinc finger domains. J Mol Biol 303:489-502. (Pubitemid 30835606)
27. Dreier B, Fuller RP, Segal DJ, Lund CV, Blancafort P, Huber A, Koksch B, Barbas CF (2005) Development of zinc finger domains for recognition of the 5′-CNN-3′ family DNA sequences and their use in the construction of artificial transcription factors. J Biol Chem 280:35588-35597.
28. Dreier B, Beerli RR, Segal DJ, Flippin JD, Barbas CF (2001) Development of zinc finger domains for recognition of the 5′-ANN-3′ family of DNA sequences and their use in the construction of artificial transcription factors. J Biol Chem 276:29466-29478. (Pubitemid 37452042)
29. Blancafort P, Segal DJ, Barbas CF (2004) Designing transcription factor architectures for drug discovery. Mol Pharmacol 66:1361-1371. (Pubitemid 39564763)
30. Mandell JG, Barbas CF (2006) Zinc finger tools: custom DNA-binding domains for transcription factors and nucleases. Nucleic Acids Res 34:W516-W523.
31. Altschul SF, Madden TL, Schäffer AA, Zhang J, Zhang Z, Miller W, Lipman DJ (1997) Gapped BLAST and PSIBLAST: a new generation of protein database search programs. Nucleic Acids Res 25:3389-3402. (Pubitemid 27359211)
32. Deprez E, Barbe S, Kolaski M, Leh H, Zouhiri F, Auclair C, Brochon JC, Le Bret M, Mouscadet JF (2004) Mechanism of HIV-1 integrase inhibition by styrylquinoline derivatives in vitro. Mol Pharmacol 65:85-98. (Pubitemid 38113889)
33. Bugreev DV, Baranova S, Zakharova OD, Parissi V, Desjobert C, Sottofattori E, Balbi A, Litvak S, Tarrago-Litvak L, Nevinsky GA (2003) Dynamic, thermodynamic, and kinetic basis for recognition and transformation of DNA by human immunodeficiency virus type 1 integrase. Biochemistry 42:9235-9247. (Pubitemid 36935434)
34. Segal DJ, Crotty JW, Bhakta MS, Barbas CF, Horton NC, Mandell JG, Eberhardy SR, Goncalves J, Coelho S, Berkhout B, Dreier B, Fuller R, Lund CV, Blancafort P, Huber A, Koksch B (2006) Structure of Aart, a designed six-finger zinc finger peptide, bound to DNA. J Mol Biol 363:405-421.
35. Balakrishnan M, Jonsson CB (1997) Functional identification of nucleotides conferring substrate specificity to retroviral integrase reactions. J Virol 71:1025-1035. (Pubitemid 27030273)
36. Katzman M, Sudol M (1996) Influence of subterminal viral DNA nucleotides on differential susceptibility to cleavage by human immunodeficiency virus type 1 and visna virus integrases. J Virol 70:9069-9073. (Pubitemid 26378501)
37. Yoshinaga T, Fujiwara T (1995) Different roles of bases within the integration signal sequence of human immunodeficiency virus type 1 in vitro. J Virol 69:3233-3236.
38. Van den Ent FM, Vink C, Plasterk RH (1994) DNA substrate requirements for different activities of the human immunodeficiency virus type 1 integrase protein. J Virol 68:7825-7832. (Pubitemid 24362669)
39. Vink C, Van Gent DC, Elgersma Y, Plasterk RH (1991) Human immunodeficiency virus integrase protein requires a subterminal position of its viral DNA recognition sequence for efficient cleavage. J Virol 65:4636-4644.
40. Lafemina RL, Callahan PL, Cordingley MG (1991) Substrate specificity of recombinant human immunodeficiency virus integrase protein. J Virol 65:5624-5630.
41. Reynolds L, Ullman C, Moore M, Isalan M, West MJ, Clapham P, Klug A, Choo Y (2003) Repression of the HIV-1 5′ LTR promoter and inhibition of HIV-1 replication by using engineered zinc-finger transcription factors. Proc Natl Acad Sci USA 100:1615-1620.
42. Segal DJ, Goncalves J, Eberhardy S, Swan CH, Torbett BE, Li X, Barbas CF (2004) Attenuation of HIV-1 replication in primary human cells with a designed zinc finger transcription factor. J Biol Chem 279:14509-14519. (Pubitemid 38618838)
43. Rebar EJ, Huang Y, Hickey R, Nath AK, Meoli D, Nath S, Chen B, Xu L, Liang Y, Jamieson AC, Zhang L, Spratt SK, Case CC, Wolffe A, Giordano FJ (2002) Induction of angiogenesis in a mouse model using engineered transcription factors. Nat Med 8:1427-1432.
44. Lanao JM, Briones E, Colino CI (2007) Recent advances in delivery systems for anti-HIV1 therapy. J Drug Target 15:21-36.
45. Whitcomb JM, Kumar R, Hughes SH (1990) Sequence of the circle junction of human immunodeficiency virus type 1: implications for reverse transcription and integration. J Virol 64:4903-4906. (Pubitemid 20329811)
46. Grote A, Hiller K, Scheer M, Munch R, Nortemann B, Hempel DC, Jahn D (2005) JCat: a novel tool to adapt codon usage of a target gene to its potential expression host. Nucleic Acids Res 33:W526-W531. (Pubitemid 44529976)
47. Wilkins MR, Gasteiger E, Bairoch A, Sanchez JC, Williams KL, Appel RD, Hochstrasser DF (1999) Protein identification and analysis tools in the ExPASy server. Methods Mol Biol 112:531-552.
48. Nair R, Rost B (2005) Mimicking cellular sorting improves prediction of subcellular localization. J Mol Biol 348:85-100. (Pubitemid 40461842)
49. Stote RH, Karplus M (1995) Zinc binding in proteins and solution: a simple but accurate nonbonded representation. Proteins 23:12-31.
50. Duan Y, Wu C, Chowdhury S, Lee MC, Xiong G, Zhang W, Yang R, Cieplak P, Luo R, Lee T, Caldwell J, Wang J, Kollman P (2003) A point-charge force field for molecular mechanics simulations of proteins based on condensed-phase quantum mechanical calculations. J Comput Chem 24:1999-2012.
51. Jorgensen WL, Chandrasekhar J, Madura JD, Impey RW, Klein ML (1983) Comparison of simple potential functions for simulating liquid water. J Chem Phys 79:926-935.
52. Jiranusornkul S, Laughton CA (2008) Destabilization of DNA duplexes by oxidative damage at guanine: implications for lesion recognition and repair. J R Soc Interface 5 (Suppl 3):S191-S198.
53. Onufriev A, Bashford D, Case DA (2000) Modification of the generalized Born model suitable for macromolecules. J Phys Chem B 104:3712-3720. (Pubitemid 30858501)